The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines

OBJECTIVE: Cholangiocarcinoma (CCA) is a noxious malignancy of epithelium of the bile duct with a low response rate to chemotherapy. The epidermal growth factor receptor (EGFR) signaling pathway is implicated in the development of cancerous cells, especially CCA. In this study, we report detailed bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Samatiwat, Papavee, Tabtimmai, Lueacha, Suphakun, Prapasri, Jiwacharoenchai, Nattanan, Toviwek, Borvorrnvat, Kukongviriyapan, Veerapol, Gleeson, M. Paul, Choowongkomon, Kiattawee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190356/
https://www.ncbi.nlm.nih.gov/pubmed/33639651
http://dx.doi.org/10.31557/APJCP.2021.22.2.381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190356/
https://www.ncbi.nlm.nih.gov/pubmed/33639651
http://dx.doi.org/10.31557/APJCP.2021.22.2.381

Ejemplares similares